Ketogenic parenteral nutrition in three paediatric patients with epilepsy with migrating focal seizures

Marisa Armeno1, Antonella Verini1, Maria B Araujo1

  • 1Department of Nutrition.

Insights

Ketogenic parenteral nutrition (KPN) offers a viable treatment for infants with epilepsy of infancy with migrating focal seizures (EIMFS) when enteral feeding is not possible. Even lower ketogenic ratios via KPN can effectively control seizures, allowing for intestinal rest.

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Clinical Nutrition

Background:

  • Epilepsy of infancy with migrating focal seizures (EIMFS) is a rare epilepsy syndrome with onset before six months.
  • The ketogenic diet (KD) is a treatment option for EIMFS, but enteral feeding can be challenging.
  • Patients with EIMFS on KD may require parenteral nutrition due to gastrointestinal issues.

Purpose of the Study:

  • To evaluate the feasibility and efficacy of ketogenic parenteral nutrition (KPN) in EIMFS patients.
  • To assess seizure control and nutritional support in patients unable to tolerate enteral feeding.

Main Methods:

  • Case series of three EIMFS patients requiring parenteral nutrition.
  • Administration of KPN with a maximum ketogenic ratio of 1.5:1.
  • Monitoring of seizure control and nutritional status.

Main Results:

  • KPN allowed for short-term bowel rest in all three patients.
  • A ketogenic ratio of 1.5:1 was adequate for seizure control in these cases.
  • Patients tolerated KPN despite lower ratios than typically used in enteral KD.

Conclusions:

  • Ketogenic parenteral nutrition is a potential therapeutic option for EIMFS patients when enteral nutrition is not feasible.
  • Lower ketogenic ratios may be sufficient for seizure control in the context of KPN.
  • Careful management is needed to maintain ketosis and avoid carbohydrates during KPN.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
210
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
540
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
581
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.1K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
668